impact factor
logo
 

shopping cart

Confirmation
purchase
Item
Code
Item DescriptionPrice
CER13103Utilisation patterns and clinical impact of the introduction of infliximab-biosimilar in Tuscany, Italy: real world evidence following the recommendation of switching for non-medical reasons20.00 €
 Subtotal 20.00 €